Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Bacharach

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
BMC Ophthalmology|June 15, 2011
A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapyJoel M Fain, Sameer Kotak, Jack Mardekian, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 10, 2022
First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract SurgeryJason Bacharach, Cathleen McCabe, Mitchell Jackson, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2021
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical TrialsDavid L Wirta, Michael S Korenfeld, Shane Foster, et al.
American Journal of Ophthalmology|March 27, 2025
Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES StudyTanner J Ferguson, Thomas W Samuelson, Leon Herndon, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 2, 2021
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial ResultsJason Bacharach, David L Wirta, Robert Smyth-Medina, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 21, 2022
Topical Review: An Update of Diagnostic and Management Algorithms for Acquired BlepharoptosisKelly K Nichols, Kelly A Malloy, Paul M Karpecki, et al.
Ophthalmology and Therapy|January 26, 2026
Perfluorohexyloctane Ophthalmic Solution in Patients with Dry Eye Disease Undergoing Cataract Surgery: A Prospective Multicenter StudyJohn A Hovanesian, Eva Liang, Neel R Desai, et al.
BMC Ophthalmology|July 29, 2016
Repeatability of selective laser trabeculoplasty for open-angle glaucomaBrian A Francis, Nils Loewen, Bryan Hong, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2016
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular EdemaCarmen A Puliafito, Scott W Cousins, Jason Bacharach, et al.
Cornea|July 16, 2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 StudiesRanjan Malhotra, Douglas K Devries, Jodi Luchs, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
BMC Ophthalmology|June 15, 2011
A multicenter, retrospective chart review study comparing index therapy change rates in open-angle glaucoma or ocular hypertension patients newly treated with latanoprost or travoprost-Z monotherapyJoel M Fain, Sameer Kotak, Jack Mardekian, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 10, 2022
First Real-World, Multicenter, Post-Marketing, Retrospective Study of Dexamethasone Intraocular Suspension for Inflammation After Cataract SurgeryJason Bacharach, Cathleen McCabe, Mitchell Jackson, et al.
Clinical Ophthalmology (Auckland, N.Z.)|October 22, 2021
Safety of Once-Daily Oxymetazoline HCl Ophthalmic Solution, 0.1% in Patients with Acquired Blepharoptosis: Results from Four Randomized, Double-Masked Clinical TrialsDavid L Wirta, Michael S Korenfeld, Shane Foster, et al.
American Journal of Ophthalmology|March 27, 2025
Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES StudyTanner J Ferguson, Thomas W Samuelson, Leon Herndon, et al.
Clinical Ophthalmology (Auckland, N.Z.)|July 2, 2021
Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial ResultsJason Bacharach, David L Wirta, Robert Smyth-Medina, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|January 21, 2022
Topical Review: An Update of Diagnostic and Management Algorithms for Acquired BlepharoptosisKelly K Nichols, Kelly A Malloy, Paul M Karpecki, et al.
Ophthalmology and Therapy|January 26, 2026
Perfluorohexyloctane Ophthalmic Solution in Patients with Dry Eye Disease Undergoing Cataract Surgery: A Prospective Multicenter StudyJohn A Hovanesian, Eva Liang, Neel R Desai, et al.
BMC Ophthalmology|July 29, 2016
Repeatability of selective laser trabeculoplasty for open-angle glaucomaBrian A Francis, Nils Loewen, Bryan Hong, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|April 21, 2016
Forming a Consensus: Data and Guidance for Physicians Treating Diabetic Macular EdemaCarmen A Puliafito, Scott W Cousins, Jason Bacharach, et al.
Cornea|July 16, 2019
Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 StudiesRanjan Malhotra, Douglas K Devries, Jodi Luchs, et al.
Pageof 5